Targeted Therapy in Pancreatic Ductal Adenocarcinoma: Current Advances and Challenges

Ramy Habib, Erika Arnold, Tasin Obi, Franco J. Vizeacoumar, Shahid Ahmed

Open source

DOI
10.3390/curroncol33080452
Published
2026-07-28
Container
Current Oncology
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/curroncol33080452,
  title = {Targeted Therapy in Pancreatic Ductal Adenocarcinoma: Current Advances and Challenges},
  author = {Ramy Habib and Erika Arnold and Tasin Obi and Franco J. Vizeacoumar and Shahid Ahmed},
  year = {2026},
  journal = {Current Oncology},
  doi = {10.3390/curroncol33080452},
  url = {https://doi.org/10.3390/curroncol33080452}
}

RIS

TY  - JOUR
TI  - Targeted Therapy in Pancreatic Ductal Adenocarcinoma: Current Advances and Challenges
AU  - Ramy Habib
AU  - Erika Arnold
AU  - Tasin Obi
AU  - Franco J. Vizeacoumar
AU  - Shahid Ahmed
PY  - 2026
JO  - Current Oncology
DO  - 10.3390/curroncol33080452
UR  - https://doi.org/10.3390/curroncol33080452
ER  - 

APA

Habib, R., Arnold, E., Obi, T., Vizeacoumar, F. J., & Ahmed, S. (2026). Targeted Therapy in Pancreatic Ductal Adenocarcinoma: Current Advances and Challenges. Current Oncology. https://doi.org/10.3390/curroncol33080452

Source records